Ken Griffin 908 Devices Inc. Put Options Transaction History

Citadel Advisors LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	SELL	$5.0 - $7.24 $6,500 - $9,412	-1,300 Reduced 48.15%	1,400 $7,000
Q1 2024 May 15, 2024	BUY	$6.55 - $9.92 $11,790 - $17,856	1,800 Added 200.0%	2,700 $20,000
Q4 2023 Feb 14, 2024	BUY	$4.96 - $12.41 $4,464 - $11,169	900 New	900 $10,000
Q2 2023 Aug 14, 2023	SELL	$5.78 - $10.02 $2,312 - $4,008	-400 Reduced 10.26%	3,500 $24,000
Q1 2023 May 15, 2023	SELL	$6.61 - $10.66 $8,593 - $13,858	-1,300 Reduced 25.0%	3,900 $33,000
Q4 2022 Feb 14, 2023	BUY	$7.0 - $17.96 $36,400 - $93,392	5,200 New	5,200 $39,000

19.5M

14.8K

4.9K

Ticker MASS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,590,200
Market Cap $115M
Description
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.